Rpo »

Fate Therapeutics shares owned by Rpo

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Rpo from 13F filings

Historical chart of Rpo investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Rpo consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Rpo

Quarter filed Position value Share count Share price at filing
2023-12-31 $46k 12k 3.74

More positions owned by Rpo

stock
Abrdn Healthcare Investors Sh Ben Int (HQH)
Nuveen Multi-Strategy Income & Growth (JPC)
Abrdn Life Sciences Investor Sh Ben Int (HQL)
Flaherty & Crumrine/Claymore Preferred S (FFC)
Blackrock Science & Technolo Shs Ben Int (BSTZ)
Flaherty & Crumrine Dynamic SHS (DFP)
Gabelli Dividend & Income Trust (GDV)
Blackrock Muniyield Fund (MYD)
Calamos Global Dynamic Income Fund (CHW)
Duff & Phelps Global (DPG)
Royce Value Trust (RVT)
Blackrock Munivest Fund II (MVT)
Boulder Growth & Income Fund (STEW)
Capri Holdings SHS (CPRI)

View all positions for Rpo

Top funds holding Fate Therapeutics

Redmile Group
Vanguard Group
Bellevue Group
D. E. Shaw & Co
Point72 Asset Management
Citadel Advisors
Jacobs Levy Equity Management
Assenagon Asset Management
Monaco Asset Management SAM
Jpmorgan Chase & Co
Casdin Capital
Two Sigma Advisers
Federated Investors
Two Sigma Investments
Charles Schwab Investment Management

View all funds holding Fate Therapeutics